EID Parry (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 8, 2025, 6:14 am

Competitors of EID Parry (India) Ltd

All Competitor Stocks of EID Parry (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:20 am

Below is a detailed analysis of the quarterly data for EID Parry (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 8,724.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,811.00 Cr. (Mar 2025) to 8,724.00 Cr., marking an increase of 1,913.00 Cr..
• For Expenses, as of Jun 2025, the value is 7,918.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,298.00 Cr. (Mar 2025) to 7,918.00 Cr., marking an increase of 1,620.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 805.00 Cr.. The value appears strong and on an upward trend. It has increased from 513.00 Cr. (Mar 2025) to 805.00 Cr., marking an increase of 292.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 9.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 90.00 Cr.. The value appears to be declining and may need further review. It has decreased from 459.00 Cr. (Mar 2025) to 90.00 Cr., marking a decrease of 369.00 Cr..
• For Interest, as of Jun 2025, the value is 104.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 96.00 Cr. (Mar 2025) to 104.00 Cr., marking an increase of 8.00 Cr..
• For Depreciation, as of Jun 2025, the value is 176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 142.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 34.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 615.00 Cr.. The value appears to be declining and may need further review. It has decreased from 735.00 Cr. (Mar 2025) to 615.00 Cr., marking a decrease of 120.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 25.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 539.00 Cr. (Mar 2025) to 464.00 Cr., marking a decrease of 75.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.85. The value appears to be declining and may need further review. It has decreased from 16.12 (Mar 2025) to 13.85, marking a decrease of 2.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:24 am

Growth

Last Updated: September 5, 2025, 3:20 am

Balance Sheet

Last Updated: July 25, 2025, 3:18 pm

Below is a detailed analysis of the balance sheet data for EID Parry (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
• For Reserves, as of Mar 2025, the value is 7,918.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,040.00 Cr. (Mar 2024) to 7,918.00 Cr., marking an increase of 878.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,704.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,740.00 Cr. (Mar 2024) to 2,704.00 Cr., marking an increase of 964.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 13,731.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,688.00 Cr. (Mar 2024) to 13,731.00 Cr., marking an increase of 1,043.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 24,371.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21,487.00 Cr. (Mar 2024) to 24,371.00 Cr., marking an increase of 2,884.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,148.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,896.00 Cr. (Mar 2024) to 6,148.00 Cr., marking an increase of 1,252.00 Cr..
• For CWIP, as of Mar 2025, the value is 422.00 Cr.. The value appears to be declining and may need further review. It has decreased from 520.00 Cr. (Mar 2024) to 422.00 Cr., marking a decrease of 98.00 Cr..
• For Investments, as of Mar 2025, the value is 1,453.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,275.00 Cr. (Mar 2024) to 1,453.00 Cr., marking an increase of 178.00 Cr..
• For Other Assets, as of Mar 2025, the value is 16,348.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,796.00 Cr. (Mar 2024) to 16,348.00 Cr., marking an increase of 1,552.00 Cr..
• For Total Assets, as of Mar 2025, the value is 24,371.00 Cr.. The value appears strong and on an upward trend. It has increased from 21,487.00 Cr. (Mar 2024) to 24,371.00 Cr., marking an increase of 2,884.00 Cr..

Notably, the Reserves (7,918.00 Cr.) exceed the Borrowings (2,704.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for EID Parry (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 49.47. This value is within the healthy range. It has decreased from 50.68 (Mar 24) to 49.47, marking a decrease of 1.21.
• For Diluted EPS (Rs.), as of Mar 25, the value is 49.33. This value is within the healthy range. It has decreased from 50.61 (Mar 24) to 49.33, marking a decrease of 1.28.
• For Cash EPS (Rs.), as of Mar 25, the value is 131.53. This value is within the healthy range. It has increased from 116.41 (Mar 24) to 131.53, marking an increase of 15.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.33. It has decreased from 631.66 (Mar 24) to 446.33, marking a decrease of 185.33.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 446.33. It has decreased from 631.66 (Mar 24) to 446.33, marking a decrease of 185.33.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,777.76. It has increased from 1,657.08 (Mar 24) to 1,777.76, marking an increase of 120.68.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 171.34. This value is within the healthy range. It has increased from 164.47 (Mar 24) to 171.34, marking an increase of 6.87.
• For PBIT / Share (Rs.), as of Mar 25, the value is 142.52. This value is within the healthy range. It has increased from 140.76 (Mar 24) to 142.52, marking an increase of 1.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 141.08. This value is within the healthy range. It has increased from 124.12 (Mar 24) to 141.08, marking an increase of 16.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 102.71. This value is within the healthy range. It has increased from 92.70 (Mar 24) to 102.71, marking an increase of 10.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.40. This value is within the healthy range. It has decreased from 50.69 (Mar 24) to 49.40, marking a decrease of 1.29.
• For PBDIT Margin (%), as of Mar 25, the value is 9.63. This value is below the healthy minimum of 10. It has decreased from 9.92 (Mar 24) to 9.63, marking a decrease of 0.29.
• For PBIT Margin (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has decreased from 8.49 (Mar 24) to 8.01, marking a decrease of 0.48.
• For PBT Margin (%), as of Mar 25, the value is 7.93. This value is below the healthy minimum of 10. It has increased from 7.49 (Mar 24) to 7.93, marking an increase of 0.44.
• For Net Profit Margin (%), as of Mar 25, the value is 5.77. This value is within the healthy range. It has increased from 5.59 (Mar 24) to 5.77, marking an increase of 0.18.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 8. It has decreased from 3.05 (Mar 24) to 2.77, marking a decrease of 0.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.06. This value is below the healthy minimum of 15. It has decreased from 12.74 (Mar 24) to 11.06, marking a decrease of 1.68.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.11. This value is within the healthy range. It has decreased from 20.54 (Mar 24) to 18.11, marking a decrease of 2.43.
• For Return On Assets (%), as of Mar 25, the value is 3.60. This value is below the healthy minimum of 5. It has decreased from 4.18 (Mar 24) to 3.60, marking a decrease of 0.58.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.26, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.38. It has decreased from 1.46 (Mar 24) to 1.38, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.57, marking a decrease of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.88 (Mar 24) to 0.92, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.64. This value is within the healthy range. It has increased from 3.03 (Mar 24) to 4.64, marking an increase of 1.61.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.78 (Mar 24) to 0.00, marking a decrease of 15.78.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.75 (Mar 24) to 0.00, marking a decrease of 10.75.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.22 (Mar 24) to 0.00, marking a decrease of 84.22.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.25 (Mar 24) to 0.00, marking a decrease of 89.25.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.18. This value is within the healthy range. It has decreased from 9.88 (Mar 24) to 8.18, marking a decrease of 1.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.97. This value is within the healthy range. It has decreased from 6.57 (Mar 24) to 4.97, marking a decrease of 1.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 17,389.31. It has increased from 12,186.78 (Mar 24) to 17,389.31, marking an increase of 5,202.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 24) to 0.55, marking an increase of 0.14.
• For EV / EBITDA (X), as of Mar 25, the value is 5.71. This value is within the healthy range. It has increased from 4.17 (Mar 24) to 5.71, marking an increase of 1.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.44, marking an increase of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.21 (Mar 24) to 0.00, marking a decrease of 84.21.
• For Price / BV (X), as of Mar 25, the value is 1.76. This value is within the healthy range. It has increased from 1.37 (Mar 24) to 1.76, marking an increase of 0.39.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.44, marking an increase of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness